Fiona McFarlane

I am a partner in our London team and I advise clients on all aspects of their corporate matters, including equity capital markets transactions, public and private mergers and acquisitions, reorganisations, joint ventures and corporate governance.

I have a particular interest in assisting clients with equity capital markets (ECM) transactions and have over 10 years of experience in guiding clients through the lifecycle of a listed company. I also advise corporate finance advisers and institutions who work with listed companies. In addition to my expertise in equity capital markets, I advise clients on mergers and acquisitions transactions, private financings, reorganisations and with general corporate law queries.

I work with clients operating across a wide range of sectors, including life sciences and healthcare, technology and communications, energy, and media and entertainment. I have a great deal of experience advising on complex, cross-border transactions, with clients and targets located in jurisdictions across the world and I have particular experience in advising US companies looking to list on the London markets or completing cross border acquisitions.

I look to build and maintain great relationships with the clients I work with and I am always keen to try to help clients achieve long-term success. You can trust me to listen to what you want to achieve and to work with you, using my years of experience advising on a wide variety of corporate transactions and a solutions-focused approach, to help you to reach that goal.

• Advised Arm Holdings plc, the cutting-edge provider of semiconductor technology, as a cornerstone investor in Raspberry Pi plc's IPO on the Main Market of the London Stock Exchange.
• Acted for GenIP plc, a technology business operating within the generative artificial intelligence (GenAI) space, providing two complementary platform-based services, on its AIM listing and associated fundraise.
• Advised MicroSalt plc, a US based business commercialising a patented technology to produce full-flavour, low-sodium salt for food manufacturers and consumers, on the first AIM market initial public offering (IPO) of 2024.
• Advised AIM-, NASDAQ- and TSX-listed TransGlobe Energy Corporation on its US$307 million merger with LSE Main Market and NYSE-listed VAALCO Energy, Inc. creating a world-class African-focused E&P Company with its assets located in prolific and established basins in Egypt, Gabon, Equatorial Guinea and Canada
• Acted for Globe Invest Limited on their cash offer for AIM-listed Best of the Best plc at a price of 535 pence per share, valuing Best of the Best plc's share capital at approximately £45.3 million.
• Advised AU Brandz Co., the Seoul-based fashion group, on the acquisition of Zennar Limited, the owner of the Rockfish Weatherwear fashion brand known for its rain boots and winter shoes.
• Advised Freenome Limited on its strategic acquisition of Oncimmune Limited providing Freenome with clinical and commercial resources to complement its frontline cancer screening efforts and an entrance for the US company into the UK market.
• Advised Envision Pharma Group, a leading global technology-enabled strategic solutions partner for the life sciences industry, on their acquisition of OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions for the healthcare industry.
• Acted for NYSE-listed agilon health, Inc. in relation to their acquisition of the mphrX (My Personal Health Records) group, a leading provider of value-based care technology and interoperability solutions, advising on non-US law aspects of the transaction.
• Acted for Aser Media Pte Ltd on the sale of their 'Eleven Sports' global sports media business to leading sports platform, DAZN Group Limited.
• Acted for Safex Holdings UK Limited, the Indian agrochemicals group, in relation to their acquisition of the leading agrochemicals contract development and manufacturing organisation (CDMO) provider, Briar Chemicals Limited.